Verb Surgical Announces Kurt Azarbarzin as President and CEO

Food and Healthcare Press Releases Thursday July 25, 2019 09:06
MOUNTAIN VIEW, California--25 Jul--PRNewswire/InfoQuest
Verb Surgical Inc. today announced that Kurt Azarbarzin has joined the company as President and Chief Executive Officer, effective immediately.

"I am incredibly honored and excited to have the opportunity to lead Verb," said Azarbarzin. "The company has an incredible vision for the future of surgery. I've spent time with the technology, and believe it has the potential to transform surgery on a global scale."

Verb is building its digital surgery platform in close collaboration with Ethicon Inc., part of the Johnson & Johnson Medical Devices Companies, and Verily, part of Alphabet Inc. It has been working actively with its partner companies and with clinicians in testing the platform in preclinical labs.

"Verb is making strong progress, and the response from clinicians around the world has been very positive," said Ashley McEvoy, Executive Vice President and Worldwide Chairman, Medical Devices, Johnson & Johnson. "We are pleased to have Kurt's leadership and expertise guiding the platform towards commercialization."

"With Verb, we are developing a comprehensive technology platform aimed at transforming surgery," said Andy Conrad, CEO of Verily. "Kurt's commercial acumen and legacy of innovative R&D in minimally invasive surgery make him a welcome addition to the team."

Verb's digital surgery platform consists of five technology pillars – robotics, visualization, advanced instrumentation, connectivity, and data analytics. Verb leadership noted that the company is on pace to deliver all five to the market in what it considers to be the world's first fully connected digital surgery platform.

"I've been exposed to many surgical technologies and trends over the course of my 35 year career and truly believe that robotics and digital are the future of surgery," said Azarbarzin, who will be relocating to the San Francisco Bay Area with Verb, "and I see vast potential in what Verb is developing. I'm joining the company to change surgery for the better."

About Verb Surgical Inc.

Verb Surgical, Inc. is developing a digital surgery platform built with technology from Verily (an Alphabet company) and Ethicon Inc., a Johnson & Johnson Medical Devices company. The company was founded in 2015 to create the future of surgery by making advanced technology and information available to more patients globally. In partnership with clinicians around the world, Verb is a company dedicated to turning technology and information into actions that matter.

To learn more, connect with Verb on LinkedIn or Twitter or visit www.verbsurgical.com.
Contact: For further information, please contact media@verbsurgical.com
Logo - https://mma.prnewswire.com/media/613687/verb_surgical_Logo.jpg

Latest Press Release

Biotech Conagen Acquires Production Platform of Therapeutic Proteins

Conagen, a vertically integrated synthetic biology company located in Boston's biotech corridor, announced today that it has acquired a fermentation-based technology for the production of therapeutically useful glycoproteins. The acquisition includes...

Pneuma Respiratory, Inc. Announces New Chairman of the Board

Pneuma Respiratory, Inc. announced that Board member Jay Morgan has assumed the position of Chairman of the Board. Pneuma's previous Chairman, Walt Robb, will remain a member of the Board of Directors. Jay Morgan served as VP Global Innovation and...

Global market of dietary supplement is welcoming a rising star GLYMATE

Glymate(TM), a newly founded nutraceutical company in Southern California. Its proprietary sugar balance dietary supplement was officially announced in the United States in June 2019, marking the official launch of the global marketing of this product,...

Xinhua Silk Road: Tasly remains China#s 2019 National Tech Innovation Demonstration Enterprise

Tasly Holding Group, one of China's leading pharmaceuticals companies, has recently passed through the country's review of National Technology Innovation Demonstration Enterprise in 2019, thanks to its continuous innovations made in the recent...

SweeGen#s non-GMO Reb M Stevia Leaf Sweetener Approved in Singapore

SweeGen, Inc., a nature-based sweetener company, announced the Singapore Food Agency has added SweeGen's Reb M Stevia Leaf Sweetener to the list of permitted food additives. SweeGen's Reb M is a non-caloric stevia sweetener that provides sweetness with...

Related Topics